Correspondence 0001393905-23-000023 from Lee Pharmaceuticals, Inc. (RONN) (CIK 0000058411)
Lee Pharmaceuticals, Inc. (RONN) (CIK 0000058411)
Date: Jan. 13, 2023 · CIK: 0000058411 · Accession: 0001393905-23-000023
AI Filing Summary & Sentiment
File numbers found in text: 024-11991
Letter
VIA EDGAR Division of Corporation Finance Office of Technology U.S. Securities and Exchange Commission Re: Lee Pharmaceuticals, Inc. Form 1-A: Request for Qualification File No. 024-11991
Dear Ms. Pierce:
Lee Pharmaceuticals, Inc. (the “Company”) hereby requests qualification of the Company’s above-referenced Offering Statement on Form 1-A (“Offering Statement”) effective at 4:00 PM EDT on Tuesday, January 17, 2023, or as soon as practicable thereafter.
We appreciate your prompt attention to this matter. Please notify me if you need anything further.
Sincerely,
/s/ John B. Morgan
Show Raw Text
CORRESP 1 filename1.htm Request for Qualification LEE PHARMACEUTICALS, INC. 11 N. Water St. Mobile, Alabama 36602 JANUARY 13, 2023 VIA EDGAR Attorney Lauren Pierce Division of Corporation Finance Office of Technology U.S. Securities and Exchange Commission Re: Lee Pharmaceuticals, Inc. Form 1-A: Request for Qualification File No. 024-11991 Dear Ms. Pierce: Lee Pharmaceuticals, Inc. (the “Company”) hereby requests qualification of the Company’s above-referenced Offering Statement on Form 1-A (“Offering Statement”) effective at 4:00 PM EDT on Tuesday, January 17, 2023, or as soon as practicable thereafter. We appreciate your prompt attention to this matter. Please notify me if you need anything further. Sincerely, /s/ John B. Morgan John B. Morgan President